Rare diseases
Investigational molecules
Locations
Back to Croatia24 clinical trials in Varazdin, Croatia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CroatiaKlinicka-Ispitivanja.hr(opens in a new tab)Zenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
CroatiaStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
CroatiaA Study of Zenagamtide in Adults With Overweight or Obesity and Type 2 Diabetes
CroatiaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
CroatiaStudy of xanomeline tartrate and trospium chloride combination for treating agitation in Alzheimer's disease patients
CroatiaCroatiaStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
CroatiaCroatiaEfficacy and Safety of Letrozole SIE Compared with Oral Letrozole, Both with Ribociclib, in Postmenopausal Women with HR‑Positive, HER2‑Negative Metastatic Breast Cancer
CroatiaA study to evaluate the effectiveness of NNC0662-0419 and semaglutide in people with type 2 diabetes
CroatiaStudy on the Effects of Atuliflapon in Adults with Moderate to Severe Uncontrolled Asthma
CroatiaStudy Comparing CT-P53 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis
CroatiaThe busiest research cities in the country
What the registry says about research in the country
Extensive research focusing on Multiple Sclerosis treatments, including studies of novel therapies and comparative effectiveness of existing medications. Multiple trials are evaluating treatments for both relapsing-remitting and primary progressive forms of MS.
Several innovative compounds being tested include fenebrutinib, ocrelizumab, and ublituximab for enhanced disease management.
Comprehensive studies addressing various cardiovascular conditions, from heart failure to prevention of major cardiovascular events. Research includes innovative treatments for atrial fibrillation and stroke prevention.
Trials evaluating new compounds like milvexian and finerenone for improved cardiovascular outcomes.
Clinical research examining new treatments for moderate to severe asthma, with a focus on improving control in patients with persistent symptoms. Studies evaluating novel therapeutic approaches for better disease management.
Investigation of new compounds like atuliflapon for enhanced asthma control.
Innovative research in breast cancer treatment, particularly focusing on hormone-receptor-positive cases. Studies evaluating targeted therapies for early-stage breast cancer.
Clinical trials examining giredestrant as a potential new treatment option.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
